At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LCID Lucid Group Inc
Post-Mkt 03-30 18:51:09 EDT
9.15
-0.25
-2.66%
盘后9.18
+0.03+0.29%
18:50 EDT
High9.57Low9.07Vol5.69M
Open9.51D1 Closing9.40Amplitude5.32%
Mkt Cap3.00BTradable Cap1.15BTotal Shares327.68M
T/O52.86MT/O Rate4.53%Tradable Shares125.52M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
TIPRANKS  ·  03-30 20:28
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
Press Release: PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Dow Jones  ·  03-30 20:00
Press Release: PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
GlobeNewswire  ·  03-30 19:50
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
Lucid Diagnostics Price Target Maintained With a $2.50/Share by BTIG
Dow Jones  ·  03-30 18:36
Lucid Diagnostics Price Target Maintained With a $2.50/Share by BTIG
Is Lucid Group’s (LCID) German Dealer Pivot the Start of a New European Expansion Strategy?
Simply Wall St.  ·  03-30 18:12
Is Lucid Group’s (LCID) German Dealer Pivot the Start of a New European Expansion Strategy?
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
TIPRANKS  ·  03-30 08:02
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
These 16 stocks are a short seller's dream - likely losers no matter what the market does
Dow Jones  ·  03-29 01:04
These 16 stocks are a short seller's dream - likely losers no matter what the market does
Lucid Group’s Slide Tests Faith in EV Turnaround
TIPRANKS  ·  03-28 22:03
Lucid Group’s Slide Tests Faith in EV Turnaround
Stock Track | Lucid Group Inc Plummets 5.05% Intraday as It's Named a Prime Short Seller Target
Stock Track  ·  03-28
Stock Track | Lucid Group Inc Plummets 5.05% Intraday as It's Named a Prime Short Seller Target
Press Release: Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status
Dow Jones  ·  03-27
Press Release: Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status
These 16 stocks are a short seller's dream - likely losers no matter what the market does
Dow Jones  ·  03-27
These 16 stocks are a short seller's dream - likely losers no matter what the market does
Precision Optics 2.78M share Spot Secondary priced at $3.60
TIPRANKS  ·  03-27
Precision Optics 2.78M share Spot Secondary priced at $3.60
Lucid Diagnostics Price Target Maintained With a $3.00/Share by Needham
Dow Jones  ·  03-27
Lucid Diagnostics Price Target Maintained With a $3.00/Share by Needham
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD)
TIPRANKS  ·  03-26
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD)
Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate
Benzinga  ·  03-26
Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate
Press Release: Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Dow Jones  ·  03-26
Press Release: Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
GlobeNewswire  ·  03-26
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
Should Lucid’s New Midsize EV Platform and European Hybrid Retail Push Require Action From Lucid Group (LCID) Investors?
Simply Wall St.  ·  03-23
Should Lucid’s New Midsize EV Platform and European Hybrid Retail Push Require Action From Lucid Group (LCID) Investors?
Lucid Expands Beyond Luxury Sedans With Midsize EV And Robotaxi Plan
Simply Wall St.  ·  03-21
Lucid Expands Beyond Luxury Sedans With Midsize EV And Robotaxi Plan
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
TIPRANKS  ·  03-21
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts

Introduction

Company Name.
Lucid Group Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Lucid Group, Inc. a technology and automotive company, engages in electric vehicle technologies business. The company designs, engineers, and builds electric vehicles, EV powertrains, and battery systems. Lucid Group, Inc. was founded in 2007 and is headquartered in Newark, California. Lucid Group, Inc. operates as a subsidiary of Ayar Third Investment Company.
Issue price:
--